Compare TSEM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSEM | MEDP |
|---|---|---|
| Founded | 1993 | 1992 |
| Country | Israel | United States |
| Employees | N/A | 6600 |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 18.3B |
| IPO Year | 1996 | 2016 |
| Metric | TSEM | MEDP |
|---|---|---|
| Price | $146.39 | $656.27 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 14 |
| Target Price | $275.21 | ★ $651.31 |
| AVG Volume (30 Days) | ★ 3.2M | 293.5K |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.98 |
| EPS | N/A | ★ 13.37 |
| Revenue | N/A | N/A |
| Revenue This Year | $27.80 | $12.62 |
| Revenue Next Year | $39.15 | $6.03 |
| P/E Ratio | $66.16 | ★ $49.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $87.30 | $373.00 |
| 52 Week High | $319.94 | $693.97 |
| Indicator | TSEM | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 52.89 |
| Support Level | $129.95 | $575.64 |
| Resistance Level | $196.51 | $685.94 |
| Average True Range (ATR) | 13.36 | 19.75 |
| MACD | 0.33 | -2.12 |
| Stochastic Oscillator | 24.01 | 39.14 |
Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs) based on the design specifications of customers. The company's line of integrated circuits is incorporated into markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. It produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. The company has a geographical presence in the USA, Japan, Asia (other than Japan), and Europe.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.